1, good future. Shanghai Yuankang Animal Pharmaceutical Co., Ltd. focuses on the development, investment and operation of public 3A hospitals, and the company has a good prospect.
2. High status. Shanghai Yuankang Animal Pharmaceutical Co., Ltd. specializes in tumor immunotherapy and clinical research. By 2023, it will become the most professional cancer medical institution in China, with a high status in China.